S0635: Erlotinib and Bevacizumab in Stage IIIB and IV Bronchioloalveolar Carcinoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Howard L. West, MD
Swedish Cancer Institute at Swedish Medical Center - First Hill Campus
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
148 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Kaiser Permanente - Deer Valley
Antioch, California, United States
- Alta Bates Summit Comprehensive Cancer Center
Berkeley, California, United States
- Peninsula Medical Center
Burlingame, California, United States
- Kaiser Permanente - Fremont
Fremont, California, United States
- Kaiser Permanente Medical Center - Hayward
Hayward, California, United States
- Tibotec Therapeutics - Division of Ortho Biotech Products, Lp
Marysville, California, United States
- Kaiser Permanente Medical Center - Oakland
Oakland, California, United States
- Valley Medical Oncology Consultants - Pleasanton
Pleasanton, California, United States
- Kaiser Permanente Medical Center - Redwood City
Redwood City, California, United States
- Kaiser Permanente Medical Center - Richmond
Richmond, California, United States
- Kaiser Permanente Medical Center - Roseville
Roseville, California, United States
- Kaiser Permanente Medical Center - Sacramento
Sacramento, California, United States
- South Sacramento Kaiser-Permanente Medical Center
Sacramento, California, United States
- University of California Davis Cancer Center
Sacramento, California, United States
- California Pacific Medical Center - California Campus
San Francisco, California, United States
- Kaiser Permanente Medical Center - San Francisco Geary Campus
San Francisco, California, United States
- Kaiser Permanente Medical Center - Santa Teresa
San Jose, California, United States
- Kaiser Foundation Hospital - San Rafael
San Rafael, California, United States
- Sutter Health - Western Division Cancer Research Group
San Rafael, California, United States
- Kaiser Permanente Medical Center - Santa Clara Kiely Campus
Santa Clara, California, United States
- Kaiser Permanente Medical Center - Santa Rosa
Santa Rosa, California, United States
- Kaiser Permanente Medical Center - South San Francisco
South San Francisco, California, United States
- Kaiser Permanente Medical Facility - Stockton
Stockton, California, United States
- Tahoe Forest Cancer Center
Truckee, California, United States
- Kaiser Permanente Medical Center - Vacaville
Vacaville, California, United States
- Kaiser Permanente Medical Center - Vallejo
Vallejo, California, United States
- Sutter Solano Medical Center
Vallejo, California, United States
- Kaiser Permanente Medical Center - Walnut Creek
Walnut Creek, California, United States
- Saint Francis/mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
Hartford, Connecticut, United States
- Ccop - Atlanta Regional
Atlanta, Georgia, United States
- Northside Hospital Cancer Center
Atlanta, Georgia, United States
- Piedmont Hospital
Atlanta, Georgia, United States
- Saint Joseph'S Hospital of Atlanta
Atlanta, Georgia, United States
- Wellstar Cobb Hospital
Austell, Georgia, United States
- John B. Amos Cancer Center
Columbus, Georgia, United States
- Charles B. Eberhart Cancer Center at Dekalb Medical Center
Decatur, Georgia, United States
- Piedmont Fayette Hospital
Fayetteville, Georgia, United States
- Northeast Georgia Medical Center
Gainesville, Georgia, United States
- Gwinnett Medical Center
Lawrenceville, Georgia, United States
- Kennestone Cancer Center at Wellstar Kennestone Hospital
Marietta, Georgia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2007
- Primary completion
- 20 Jul 2019
- Completion
- 20 Aug 2019
- Last update posted
- 2 Apr 2020
- Registered enrollment
- 84
- Registry id
- NCT00436332
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.